Analystreport

Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $15.00 to $13.00.

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com